Mantle cell lymphomas: Characteristics, natural history and prognostic factors of 45 cases

Leukemia and Lymphoma

Volumn 26, Issue 5-6, 1997, Pages 539-550

  Decaudin, Didier ^a   Bosq, Jacques ^a   Munck, Jean Nicolas ^a   Bayle, Chant A L ^a   Koscielny, Serge ^a   Boudjemaa, Sabah ^a   Bennaceur, Annelise ^a   Venuat, Anne Marie ^a   Naccache, Philippe ^a   Bendahmane, Belguendouz ^a   Ribrag, Vincent ^a   Carde, Patrice ^a   Pico, José Luis ^a   Hayat, Marcel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Mantle cell lymphoma; Non Hodgkin's lymphoma

Indexed keywords

BLEOMYCIN; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW; BONE MARROW METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG RESPONSE; FEMALE; HUMAN; LEUKEMIA CELL; LIVER; LIVER METASTASIS; LYMPHOCYTOMA; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

EID: 9844224489     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709050890     Document Type: Article

References (30)

1. Banks, P. M., Chan, J., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Gatter, K., Grogan, T. M., Harris, N. L., Isaacson, P. G., Jaffe, E. S., Mason, D., Pileri, S., Ralfkiaer, E., Stein, H. and Warnke, R. A (1992). Mantle cell lymphoma: A proposal for unification of morphologic, immunologic and molecular data. Am. J. Surg. Pathol., 16, 637-640.
2. Lennert, K., Stein, H. and Kaiserling, E. (1975). Cytological and functional criteria for the classification of malignant lymphomata. Br. J. Cancer, 31, (suppl 2), 29-43.
3. Berard, C. W and Dorfman, R. F. (1974). Histopathology of malignant lymphomas. Clin. Haematol., 3, 39-76.
4. Weisenburger, D. D., Kim, H. and Rappaport, H. (1982). Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer, 49, 1429-1438.
5. The non-Hodgkin's lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of non Hodgkin's lymphomas. Summary and description of a Working formulation for clinical usage (1982). Cancer, 49, 2112-2135.
6. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K. C., Cleary, M. L., Delsos, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D., Mason, D., Muller-Hermelink, H.-K., Pileri, S. A., Piris, M., Ralfkiaer, E. and Warnke, R. (1994). A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
7. Zucca, E., Stein, H. and Coiffier, B. (1994). European Lymphoma Task Force (ELFT): Report of the workshop on Mantle Cell Lymphoma (MCL). Ann. Oncol., 5, 507-511.
8. Vandenberghe, E. (1994). Mantle cell lymphoma, Blood Reviews, 8, 79-87.
9. Bofill, M., Janossy, G., Janossa, M., Burford, G., Seymour, G., Wernet, P. and Kelemen, E. (1985). Human B cell development. II. Subpopulations in the human fetus. J. Immunol., 134, 1531-1538.
10. Williams, M., Swerdlow, S., Rosenberg, C. and Arnold, A. (1992). Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Canc. Res. Suppl., 52, 5541s-5544s (Suppl).
11. Rosenberg, C., Wong, E., Petty, E., Bale, A. E., Tsujimoto, Y., Harris, N. and Arnold, A. (1991). PRAD1, a candidate bcl-1 oncogene: Mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci., 88, 9638-9642.
12. Williams, M., Meeker, T. and Swerdlow, S. H. (1991). Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphomas: Analyse with multiple breakpoint probes. Blood, 78, 493-498.
13. Zucca, E., Roggero, E., Pinotti, G., Pedrinis, E., Cappella, C., Venco, A. and Cavalli, F. (1995). Patterns of survival in mantle cell lymphoma. Ann. Oncol, 6, 257-262.
14. Warnke, R. and Levy, R. (1980). Detection of T and B cell antigens with hybridoma monoclonal antibodies. A biotin-avidin-horseradish peroxidase method. J. Histochem Cytochem., 28, 771-776.
15. Dutrillaux, B. and Lejeune, J. (1971). On a new technique of human karyotype study, CR Acad. Sci., Paris 272, 2638-2640.
16. Mitelman, F. (1991). ISCN: Guidelines for Cancer Cytogenetics: Supplement to An International System for Cytogenetic Nomenclature, ed. Basel, Karger.
17. Berger, F., Felman, P., Sonet, A., Salles, G., Bastion, Y., Bryon, P. A. and Coiffier, B. (1994). Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood, 83, 2829-2835.
18. Duggan, M., Weisenburger, D., Ye, Y., Bast, M. A., Pierson, J. L., Linder, J. and Armitage, J. O. (1990). Mantle zone lymphoma: A clinicopathologic study of 22 cases. Cancer, 66, 522-529.
19. Fisher, R., Dahlberg, S., Nathwani, B., Banks, P. M., Miller, T. P. and Grogan, T. M. (1995). A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the Mucosa-Associated Lymphoid Tissue and monocytoid B-cell subcategories): A southwest oncology group study. Blood, 85, 1075-1082.
20. Meusers, P., Engelhard, M., Bartels, H., Binder, T., Fülle, H. H., Görg, K., Gunzer, U., Havemann, K., Kayser, W., König, E., König, H. J., Kuse, R., Löffler, H., Ludwig, W.-D., Mainzer, K., Martin, H., Pralle, H., Schoppe, W. D., Staiger, H. J., Theml, H., Zurborn, K. H., Zwingers, T. H., Lennert, K. and Brittinger, G. (1989). Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis Hematol. Oncol., 7, 365-380.
21. Norton, A. J., Matthews, J., Pappa, V., Shamash, J., Love, S., Rohatmer, A. Z. S. and Lister, T. A (1995). Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period. Ann. Oncol., 6, 249-256.
22. Teodorovic, I., Pittaluga, S., Kluin-Nelemans, J. C., Meerwaldt, J. H., Hagenbeek, A., van Glabbeke, M., Somers, R., Bijnens, L., Noordijk, E. M. and De Wolf-Peeeters, C. for the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group (1995). Efficacy of four different regimens in 64 Mantle-Cell Lymphomas cases: clinicopathologic comparaison with 498 other non-Hodgkin's lymphoma subtypes. J. Clin. Oncol., 13, 2819-2826.
23. Pittaluga, S., Wlodarska, I., Stul, M. S., Homas, J., Verhoef, G., Cassiman, J. J., Van Den Bergue, H. and De Wolf-Peeters, C. (1995). Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology, 26, 17-24.
24. Segal, G. H., Masih, A. S., Fox, A. C., Jorgensen, T., Scott, M. and Braylan, R. C (1995). CDS-expressing B-cell non Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood, 85, 1570-1579.
25. Rimokh, R., Berger, F., Delsol, G., Digonnet. I., Rouault, J. P., Tigaud, J. D., Gadoux, M., Coiffier, B., Bryon, P. A and Magaud, J. P. (1994). Detection of the chromosomal translocation t (11;14) by Polymerase Chain Reaction in Mantle cell lymphomas. Blood, 83, 1871-1875.
26. Jaffe, E. S., Bookman, M. A. and Longo, D. L. (1987). Lymphocytic lymphoma of intermediate differentiation - Mantle zone lymphoma: A distinct subtype of B-Cell lymphoma. Human Pathol, 18, 877-880.
27. Leith, C. P., Spier, C. M., Grogan, T. M., Gonzales, G., Rangel, C. S., Rybski, J. A., Matzner, M. and Miller, T. P. (1992) Diffuse small cleaved-cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets. J. Clin. Oncol, 10, 1259-1265.
28. Velders, G. A., Kluin-Nelemans, J. C., De Boer, C. J., Hermans, J., Noordijk, E. M., Schuuring, E., Kramer, M. H. H., Van Deijk, W. A., Rahder, J. B., Kluin, P. M. and Van Krieken, J. H. J. M. (1996). Mantle-cell lymphoma: a population-based clinical study. J. Clin. Oncol., 14, 1269-1274.
29. Weisenburger, D. D. and Armitage, J. O. (1996). Mantle cell lymphoma- an entity comes of age. Blood, 87, 4483-4494.
30. Shivdasani, R. A., Hess, J. L., Skarin, A T. and Pinkus, G S. (1993). Intermediate lymphocytic lymphoma: clinical and pathological features of a recently characterized subtype of Non-Hodgkin's Lymphoma J. Clin. Oncol., 11, 802-811.